心脏再同步化治疗反应性的预测因素研究进展  

Predictors of Cardiac Resynchronization Therapy Response

作　　者：刘晓彤 芦颜美[1] LIU Xiaotong;LU Yanmei(Department of Cardiac Pacing and Electrophysiology,The First Affiliated Hospital of Xinjiang Medical University,Urumqi 830054,Xinjiang,China)

机构地区：[1]新疆医科大学第一附属医院心脏中心起搏电生理科,新疆乌鲁木齐830054

出　　处：《心血管病学进展》2025年第3期210-214,共5页Advances in Cardiovascular Diseases

基　　金：新疆维吾尔自治区天山英才-青年拔尖科技人才项目(2022TSYCCX0101)。

摘　　要：尽管心脏再同步化治疗在治疗电学失同步心力衰竭方面的有效性已被公认,但一部分患者仍未能达到当前手术指征所预期的结果。为了实现个体化精准治疗,同时减少医疗不必要的支出,通过术前基线指标筛选出更适合接受心脏再同步化治疗的患者至关重要。现综合分析和总结心脏再同步化治疗反应性预测因素的研究进展,为未来的研究和临床应用提供参考。Although cardiac resynchronization therapy(CRT) is recognized for its effectiveness in treating electrically asynchronous heart failure,a notable group of patients fails to meet the anticipated outcomes based on current surgical indications.It is crucial to screen patients who are more suitable for CRT through preoperative baseline indicators in order to achieve personalized and precise treatment while reducing unnecessary medical expenses.We will comprehensively analyze and summarize the research progress on the predictors of CRT response,providing reference for future research and clinical applications.

关 键 词：心脏再同步化治疗 反应性 预后 预测因素 

分 类 号：R54[医药卫生—心血管疾病]